CRISPR Medicine News

CRISPR Medicine News

About CRISPR Medicine News

Welcome to CRISPR Medicine News.
We are a global independent online media writing about gene therapy and genome editing.

Read more.

Learn - Innovate - Access

CLINICAL TRIALS
Non-small Cell Lung Cancer, NSCLC, (NCT06097962)
Sponsors:
Base Therapeutics (Shanghai) Co., Ltd.
Indicator
IND Enabling
Phase I
Phase II
Phase III
Gastric Cancer and Colorectal Cancer, CRC, (NCT07166263)
Sponsors:
Base Therapeutics (Shanghai) Co., Ltd.  
Indicator
IND Enabling
Phase I
Phase II
Phase III
Relapsed or Refractory Acute Myeloid Leukemia, AML, (NCT06541444)
Sponsors:
Base Therapeutics (Shanghai) Co., Ltd.
Indicator
IND Enabling
Phase I
Phase II
Phase III
View all clinical trials
CRISPR Medicine News
Harvard Medical School (@HMS)

Genome Engineering Seminar Series (GESS)

Read more...Harvard Medical School (@HMS)
Join WDC Chat Community
WDC Chat Community
close
Search CRISPR Medicine